• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ItalyChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Chronic Spontaneous Urticaria Mechanism of Disease Animation
Dermatology
4 min
videoanimation

Chronic Spontaneous Urticaria Mechanism of Disease Animation

ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Dermatology
20 min
Podcast

ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis

Exacerbations Lead to Worsening Lung Function
Type 2 Inflammation
2 min
expert video

Exacerbations Lead to Worsening Lung Function

Role of Type 2 Cytokines in Asthma and COPD
Type 2 Inflammation
2 min
expert video

Role of Type 2 Cytokines in Asthma and COPD

Impact of Exacerbations in COPD
Type 2 Inflammation
2 min
expert video

Impact of Exacerbations in COPD

Clinical Manifestations Associated With Airway Remodeling in Asthma
Type 2 Inflammation
2 min
expert video

Clinical Manifestations Associated With Airway Remodeling in Asthma

Potential Role of Type 2 Inflammation in the Pathogenesis of CSU
Dermatology
2 min
expert video

Potential Role of Type 2 Inflammation in the Pathogenesis of CSU

Pathophysiology of Bullous Pemphigoid
Dermatology
4 min
expert video

Pathophysiology of Bullous Pemphigoid

Diagnosis and Clinical Manifestations of Bullous Pemphigoid
Dermatology
2 min
expert video

Diagnosis and Clinical Manifestations of Bullous Pemphigoid

Unmet Needs in Bullous Pemphigoid
Dermatology
3 min
expert video

Unmet Needs in Bullous Pemphigoid

The Pathophysiology of Prurigo Nodularis
Dermatology
5 min
videoanimation

The Pathophysiology of Prurigo Nodularis

Persistence of AD From Childhood Into Adulthood
Dermatology
3 min
expert video

Persistence of AD From Childhood Into Adulthood

    1
    ...
    101112
    ...
    25